PDC
Phosducin
Also known as: MEKA, PHOS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20941
- Gene
- PDC
- Ensembl
- ENSG00000116703
- Chromosome
- 1
- Canonical length
- 246 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a phosphoprotein, which is located in the outer and inner segments of the rod cells in the retina. This protein may participate in the regulation of visual phototransduction or in the integration of photoreceptor metabolism. It modulates the phototransduction cascade by interacting with the beta and gamma subunits of the retinal G-protein transducin. This gene is a potential candidate gene for retinitis pigmentosa and Usher syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
246 residues, UniProt reviewed canonical sequence.
>P20941|PDC
1 MEEAKSQSLE EDFEGQATHT GPKGVINDWR KFKLESQDSD SIPPSKKEIL RQMSSPQSRN
61 GKDSKERVSR KMSIQEYELI HKEKEDENCL RKYRRQCMQD MHQKLSFGPR YGFVYELETG
121 KQFLETIEKE LKITTIVVHI YEDGIKGCDA LNSSLTCLAA EYPIVKFCKI KASNTGAGDR
181 FSLDVLPTLL IYKGGELISN FISVAEQFAE EFFAGDVESF LNEYGLLPER EVHVLEHTKI
241 EEEDVELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 619 nTPM
Expression across tissuesHPA
Tissue
- retina: 619 nTPM
- cerebellum: 0.3 nTPM
- skeletal muscle: 0.2 nTPM
- cerebral cortex: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- pancreas: 0.1 nTPM
Single-cell type
- rod photoreceptor cells: 904 nCPM
- cone photoreceptor cells: 621 nCPM
- müller glia: 33 nCPM
- cardiomyocytes: 24 nCPM
- retinal bipolar cells: 17 nCPM
- myonuclei: 16 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 8.4 nTPM
- cerebral cortex: 7.8 nTPM
- white matter: 6.1 nTPM
- basal ganglia: 5.2 nTPM
- amygdala: 4.4 nTPM
- spinal cord: 4.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDC.
Disease | AutoantibodyPubMed
Conditions in which antibodies against PDC are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for PDC from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
15 publications
- Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
2014 · Arthritis Rheumatol · RCR 6.8 · 240 citations - Antibodies to pancreatic duct cells in Sjögren's syndrome and rheumatoid arthritis.
1977 · Gut · RCR 2.2 · 47 citations - The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples.
2001 · J Gastroenterol · RCR 1.2 · 48 citations - Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens.
1992 · Int Arch Allergy Immunol · RCR 0.8 · 22 citations - Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
2001 · J Gastroenterol Hepatol · RCR 0.7 · 20 citations
Show 10 more
- Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.
2020 · Front Med (Lausanne) · RCR 0.6 · 9 citations - Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis.
1995 · Arthritis Rheum · RCR 0.6 · 18 citations - The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X?
1997 · Gastroenterology · RCR 0.5 · 21 citations - Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
2003 · Clin Biochem · RCR 0.5 · 19 citations - Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
2003 · Dig Dis Sci · RCR 0.4 · 15 citations - Secretory autoantibodies in primary biliary cirrhosis (PBC).
2000 · Clin Exp Immunol · RCR 0.3 · 16 citations - A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse.
2005 · Hepatology · RCR 0.3 · 14 citations - Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
2007 · Blood · RCR 0.2 · 9 citations - Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
2006 · Liver Int · RCR 0.2 · 8 citations - Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis.
1996 · J Hepatol · RCR 0.1 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- phototransduction
- regulation of G protein-coupled receptor signaling pathway
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDC as an antibody target. Whether an autoantibody or antibody against PDC could matter depends on whether native PDC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...